ARTICLE | Clinical News
PCSK9si: Interim Ph II data
November 3, 2016 11:21 PM UTC
Interim data from the double-blind, placebo-controlled, international Phase II ORION-1 trial in 501 patients with atherosclerotic cardiovascular disease or atherosclerotic cardiovascular disease-risk ...
BCIQ Target Profiles